{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:03:16Z","timestamp":1780635796077,"version":"3.54.1"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Allergic rhinitis (AR) is an IgE-dependent, Th2 cell-mediated disorder that significantly impairs patients\u2019 quality of life. In recent years, molecular innate immune regulation has emerged as a pivotal area of research, especially focusing on the use of Toll-like receptor (TLR) agonists as adjuvants in allergen immunotherapy (AIT). TLRs, key components of the innate immune system, recognize pathogen-associated molecular patterns and activate dendritic cells, thereby modulating adaptive immune responses to promote anti-allergic immune deviation. This review provides a comprehensive overview of the role of TLRs in the development of AR vaccines, summarizing the progress made with various TLR agonists and their potential applications in AIT. Emphasis is placed on the immunoregulatory characteristics of these molecules and the current status of clinical trials, aiming to offer a theoretical foundation and research direction for the design of more effective and fast-acting therapeutic strategies for allergic rhinitis.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1769878","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:37:09Z","timestamp":1780634229000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in molecular innate immune regulation in the development and therapeutic strategies of allergic rhinitis vaccines"],"prefix":"10.3389","volume":"17","author":[{"given":"Yiting","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Precise Diagnosis and Treatment of Upper Airway Allergic Diseases, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Otolaryngology Head and Neck Surgery Research Center, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuida","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Precise Diagnosis and Treatment of Upper Airway Allergic Diseases, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Otolaryngology Head and Neck Surgery Research Center, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Sha","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Precise Diagnosis and Treatment of Upper Airway Allergic Diseases, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Otolaryngology Head and Neck Surgery Research Center, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Precise Diagnosis and Treatment of Upper Airway Allergic Diseases, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Otolaryngology Head and Neck Surgery Research Center, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjia","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Jilin Provincial Key Laboratory of Precise Diagnosis and Treatment of Upper Airway Allergic Diseases, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]},{"name":"Otolaryngology Head and Neck Surgery Research Center, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trial Research Laboratory, China-Japan Union Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1067327","article-title":"What are the changes in the nasal mucosa caused by allergic rhinitis?","volume":"133","author":"Klimek","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/all.15729","article-title":"Immunomodulatory properties of mesenchymal stem cells: a potential therapeutic strategy for allergic rhinitis","volume":"78","author":"Wang","year":"2023","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2004.02.001","article-title":"Influences of allergic rhinitis on sleep","volume":"130","author":"Ferguson","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6121.1000202","article-title":"Treatment of allergic rhinitis","volume":"81","author":"Sur","year":"2010","journal-title":"Am Fam Physician"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/aci.0000000000000921","article-title":"Highlights of the treatment of allergic rhinitis according to Chinese guidelines","volume":"23","author":"Zhang","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0325","article-title":"Mechanisms of allergen immunotherapy supporting its disease-modifying effect","volume":"14","author":"Bumbacea","year":"2022","journal-title":"Immunotherapy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.13-rai-0650","article-title":"Allergen immunotherapy and tolerance","volume":"62","author":"Matsuoka","year":"2013","journal-title":"Allergol Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.01.016","article-title":"Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma","volume":"149","author":"Shamji","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13223-016-0140-2","article-title":"Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence","volume":"12","author":"Demoly","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.s242957","article-title":"Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma","volume":"14","author":"Vogelberg","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/164_2021_543","article-title":"Toll-like receptors in adaptive immunity","volume":"276","author":"Kumar","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-010-0600-x","article-title":"Toll-like receptors in innate immunity and infectious diseases","volume":"4","author":"Wu","year":"2010","journal-title":"Front Med China"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1143583","article-title":"Toll-like receptors in cardiac hypertrophy","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000086657","article-title":"TLR signalling and the function of dendritic cells","volume":"86","author":"Hemmi","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3366-3_15","article-title":"Study of agonists of TLRs as vaccine adjuvants","volume":"2700","author":"Mancini","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080743","article-title":"TLR2 ligands induce NF-\u03baB activation from endosomal compartments of human monocytes","volume":"8","author":"Brandt","year":"2013","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012871","article-title":"Human integrin \u03b1(3)\u03b2(1) regulates TLR2 recognition of lipopeptides from endosomal compartments","volume":"5","author":"Marre","year":"2010","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3335-8_4","article-title":"Using confocal microscopy to investigate intracellular trafficking of toll-like receptors","volume":"1390","author":"Husebye","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2014.05.004","article-title":"Innate and intrinsic antiviral immunity in skin","volume":"75","author":"Kawamura","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7554\/elife.00291","article-title":"UNC93B1 mediates differential trafficking of endosomal TLRs","volume":"2","author":"Lee","year":"2013","journal-title":"Elife"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501305","article-title":"LRRC59 regulates trafficking of nucleic acid-sensing TLRs from the endoplasmic reticulum via association with UNC93B1","volume":"195","author":"Tatematsu","year":"2015","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2010.03.012","article-title":"Toll-like receptors in ocular surface disease","volume":"90","author":"Redfern","year":"2010","journal-title":"Exp Eye Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3109\/10799893.2014.903418","article-title":"Role of toll-like receptors in lung cancer","volume":"34","author":"Yang","year":"2014","journal-title":"J Recept Signal Transduct Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/mec.13437","article-title":"Drift, not selection, shapes toll-like receptor variation among oceanic island populations","volume":"24","author":"Gonzalez-Quevedo","year":"2015","journal-title":"Mol Ecol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232282","article-title":"Adaptive genetic diversity and evidence of population genetic structure in the endangered Sierra Madre Sparrow (Xenospiza baileyi)","volume":"15","author":"Ham-Due\u00f1as","year":"2020","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2013.11.013","article-title":"Toll-like receptors (TLRs) in aquatic animals: signaling pathways, expressions and immune responses","volume":"158","author":"Rauta","year":"2014","journal-title":"Immunol Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4067\/s0716-97602007000200001","article-title":"Toll-like receptors are key participants in innate immune responses","volume":"40","author":"Arancibia","year":"2007","journal-title":"Biol Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m113.490946","article-title":"Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells","volume":"288","author":"Loiarro","year":"2013","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2014.11.003","article-title":"Role of toll-like receptors in multiple myeloma and recent advances","volume":"43","author":"Thakur","year":"2015","journal-title":"Exp Hematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathophys.2019.07.005","article-title":"Camphor elicits up-regulation of hepatic and pulmonary pro-inflammatory cytokines and chemokines via activation of NF-kB in rats","volume":"26","author":"Somade","year":"2019","journal-title":"Pathophysiology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130926","article-title":"Ginseng berry extract promotes maturation of mouse dendritic cells","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"B34","article-title":"Dendritic cells and toll-like receptors in allergy and asthma","volume":"16","author":"Duez","year":"2006","journal-title":"Eur J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2021-0173","article-title":"Association of toll-like receptors 4 (TLR-4) gene expression and polymorphisms in patients with severe asthma","volume":"14","author":"Shukur","year":"2021","journal-title":"J Med Life"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405644121","article-title":"IL-1 receptor antagonism reveals a yin-yang relationship between NF\u03baB and interferon signaling in chronic lymphocytic leukemia","volume":"121","author":"Luo","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.14712\/fb2005051050148","article-title":"Toll-like receptors. I. Structure, function and their ligands","volume":"51","author":"Sandor","year":"2005","journal-title":"Folia Biol (Praha)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000088882","article-title":"Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcome of the adaptive immune response","volume":"90","author":"Pearce","year":"2006","journal-title":"Chem Immunol Allergy"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu103","article-title":"Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings","volume":"210","author":"Zhang","year":"2014","journal-title":"J Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2018.12.003","article-title":"T helper 2 differentiation is necessary for development of lymphedema","volume":"206","author":"Ly","year":"2019","journal-title":"Transl Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020142","article-title":"TLR agonists as vaccine adjuvants targeting cancer and infectious diseases","volume":"13","author":"Luchner","year":"2021","journal-title":"Pharmaceutics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)","volume":"23","author":"Weeratna","year":"2005","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03093","article-title":"Bacterial immunogenicity is critical for the induction of regulatory B cells in suppressing inflammatory immune responses","volume":"10","author":"Maerz","year":"2019","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.12304","article-title":"Regulatory and effector helper T-cell profile after nerve xenografting in the toll-like receptor-deficient mice","volume":"12","author":"Rau","year":"2015","journal-title":"Int J Med Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.2001.00458.x","article-title":"Roles of toll-like receptors in innate immune responses","volume":"6","author":"Takeda","year":"2001","journal-title":"Genes Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100109","article-title":"Physical and immunological barrier of human primary nasal epithelial cells from non-allergic and allergic donors","volume":"13","author":"Bergougnan","year":"2020","journal-title":"World Allergy Organ J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12009","article-title":"The SP-TLR axis, which locally primes the nasal mucosa, is impeded in patients with allergic rhinitis","volume":"11","author":"Larsson","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13003","article-title":"Upregulation of the expression of toll-like receptor 9 in basophils in patients with allergic rhinitis: an enhanced expression by allergens","volume":"93","author":"Zhong","year":"2021","journal-title":"Scand J Immunol"},{"key":"B49","article-title":"Hyperoxia-induced up-regulation of toll-like receptors expression in alveolar epithelial cells","volume":"23","author":"Huang","year":"2011","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000525052.04397.7f","article-title":"Normothermic ex vivo lung perfusion in brain-dead donors reduces inflammatory cytokines and toll-like receptor expression","volume":"15","author":"Shafaghi","year":"2016","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4274\/thoracrespract.2025.s013","article-title":"MSC-exosomes as novel therapeutics in asthma and allergic airway inflammation","volume":"26","author":"Kurt","year":"2025","journal-title":"Thorac Res Pract"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/536478","article-title":"Modulation of toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection","volume":"2010","author":"Pilsbury","year":"2010","journal-title":"Mediators Inflamm"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2203.03006","article-title":"Pneumococcal \u0394pep27 immunization attenuates TLRs and NLRP3 expression and relieves murine ovalbumin-induced allergic rhinitis","volume":"32","author":"Yu","year":"2022","journal-title":"J Microbiol Biotechnol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101143","article-title":"The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases","volume":"88","author":"Ciaston","year":"2022","journal-title":"Mol Aspects Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/md13085402","article-title":"The anti-inflammatory effect of algae-derived lipid extracts on lipopolysaccharide (LPS)-stimulated human THP-1 macrophages","volume":"13","author":"Robertson","year":"2015","journal-title":"Mar Drugs"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2022.220120","article-title":"Upregulation of toll-like receptors 2, 5, 7, and 9 in the cervical epithelial cells of Iranian women infected with high-risk human papilloma virus","volume":"68","author":"Douzandeh-Mobarrez","year":"2022","journal-title":"Clin Lab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343617","article-title":"Activation of human basophils by combined toll-like receptor- and Fc\u03b5RI-triggering can promote Th2 skewing of naive T helper cells","volume":"44","author":"Suurmond","year":"2014","journal-title":"Eur J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00207","article-title":"Combinatorial IL-17RB, ST2, and TSLPR signaling in dendritic cells of patients with allergic rhinitis","volume":"8","author":"Zheng","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2165\/11536140-000000000-00000","article-title":"CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma","volume":"24","author":"Gupta","year":"2010","journal-title":"BioDrugs"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.04.001","article-title":"In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant","volume":"83","author":"van Haren","year":"2016","journal-title":"Cytokine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and toll-like receptor signaling balance T(reg) cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.877","article-title":"Foxp3 expression in A549 cells is regulated by toll-like receptor 4 through nuclear factor-\u03baB","volume":"6","author":"Jia","year":"2012","journal-title":"Mol Med Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601554103","article-title":"Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa052916","article-title":"Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis","volume":"355","author":"Creticos","year":"2006","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.07.005","article-title":"TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes","volume":"45","author":"Schleimann","year":"2019","journal-title":"EBioMedicine"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/med.20214","article-title":"Prophylactic and therapeutic implications of toll-like receptor ligands","volume":"32","author":"Hedayat","year":"2012","journal-title":"Med Res Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1412s109","article-title":"Toll-like receptors","volume":"109","author":"Takeda","year":"2015","journal-title":"Curr Protoc Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04368.x","article-title":"Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis","volume":"164","author":"Chung","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1177\/1753425918771178","article-title":"TLR agonist combinations that stimulate Th type I polarizing responses from human neonates","volume":"24","author":"Surendran","year":"2018","journal-title":"Innate Immun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900986","article-title":"IDO activates regulatory T cells and blocks their conversion into Th17-like T cells","volume":"183","author":"Baban","year":"2009","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.078535","article-title":"Regulatory T cells and toll-like receptors: regulating the regulators","volume":"66","author":"Sutmuller","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599083","article-title":"Toll-like receptor agonists as adjuvants for allergen immunotherapy","volume":"11","author":"Kirtland","year":"2020","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8694-z","article-title":"Enhancing the safety and efficacy of food allergy immunotherapy: a review of adjunctive therapies","volume":"55","author":"Virkud","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173646","article-title":"Estradiol alters the immune-responsiveness of cervical epithelial cells stimulated with ligands of toll-like receptors 2 and 4","volume":"12","author":"Behnia","year":"2017","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1177\/194589240501900303","article-title":"Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway","volume":"19","author":"Dong","year":"2005","journal-title":"Am J Rhinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae287","article-title":"Mechanistic study of acupuncture on the pterygopalatine ganglion to improve allergic rhinitis: analysis of multi-target effects based on bioinformatics\/network topology strategie","volume":"25","author":"Tian","year":"2024","journal-title":"Brief Bioinform"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.12.067","article-title":"One hundred ten years of allergen immunotherapy: a broad look into the future","volume":"9","author":"Pfaar","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300424","article-title":"Immune activation profiles elicited by distinct, repeated TLR agonist infusions in rhesus macaques","volume":"211","author":"King","year":"2023","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.027","article-title":"Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release","volume":"32","author":"Ilyinskii","year":"2014","journal-title":"Vaccine"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.10.002","article-title":"Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal cationic adjuvant formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01","volume":"291","author":"Wilkinson","year":"2018","journal-title":"J Control Release"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-010-0167-0_16","article-title":"Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome","volume":"159","author":"Gherardi","year":"2003","journal-title":"Rev Neurol (Paris)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.7.1051","article-title":"Clinical investigations of toll-like receptor agonists","volume":"17","author":"Meyer","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.057","article-title":"Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses","volume":"34","author":"Julier","year":"2016","journal-title":"Vaccine"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127493","article-title":"Mycobacterium tuberculosis Hsp70 as a cancer vaccine adjuvant: immunomodulatory mechanisms and tumor microenvironment remodeling","volume":"62","author":"Liu","year":"2025","journal-title":"Vaccine"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.0c00337","article-title":"Chemical strategies to enhance the therapeutic efficacy of toll-like receptor agonist based cancer immunotherapy","volume":"53","author":"Lee","year":"2020","journal-title":"Acc Chem Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003132","article-title":"Self-assembly nanovaccine containing TLR7\/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response","volume":"9","author":"Zhang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01210","article-title":"Increasing the chemical variety of small-molecule-based TLR4 modulators: an overview","volume":"11","author":"Romerio","year":"2020","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2024.111996","article-title":"Clinical significance of T helper-1\/T helper-2 cytokines in peripheral blood of children with otitis media with effusion and allergic rhinitis","volume":"182","author":"Yu","year":"2024","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.28.608716","article-title":"Modulation of antigen delivery and lymph node activation in non-human primates by saponin adjuvant SMNP","author":"Yousefpour","year":"2024","journal-title":"bioRxiv"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1421758","article-title":"Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization","volume":"15","author":"Jackson","year":"2024","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2174\/138955706776073411","article-title":"Modifying toll-like receptor 9 signaling for therapeutic use","volume":"6","author":"Bhattacharjee","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.06.017","article-title":"Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays","volume":"40","author":"Inglefield","year":"2022","journal-title":"Vaccine"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.09.041","article-title":"A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1\/Th2 immune response in diphtheria-tetanus-pertussis vaccine","volume":"23","author":"Sugai","year":"2005","journal-title":"Vaccine"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2023.02.016","article-title":"Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy","volume":"26","author":"Su","year":"2023","journal-title":"Bioact Mater"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1259822","article-title":"The effect of toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice","volume":"13","author":"Do","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2007.0097","article-title":"TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN","volume":"28","author":"Inglefield","year":"2008","journal-title":"J Interferon Cytokine Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085587","article-title":"A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity","volume":"9","author":"Leigh","year":"2014","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1177\/1945892421993034","article-title":"Upregulated expression of toll-like receptor 7 in peripheral blood basophils of patients with allergic rhinitis","volume":"35","author":"Wang","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/aci.0000000000000212","article-title":"Toll-like receptors as targets for allergen immunotherapy","volume":"15","author":"Aryan","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-009-0080-9","article-title":"Tlr, nlr agonists, and other immune modulators as infectious disease vaccine adjuvants","volume":"12","author":"Higgins","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m607594200","article-title":"Critical role for cryopyrin\/nalp3 in activation of caspase-1 in response to viral infection and double-stranded rna","volume":"281","author":"Kanneganti","year":"2006","journal-title":"J Biol Chem"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.040","article-title":"Nlrp3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis","volume":"158","author":"Sendler","year":"2020","journal-title":"Gastroenterology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00497-25","article-title":"Orientia tsutsugamushi binds to multiple c-type lectin receptors","volume":"94","author":"Hefter","year":"2026","journal-title":"Infect Immun"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2017.1299128","article-title":"Implications of toll-like receptors in ebola infection","volume":"21","author":"Saghazadeh","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/s1081-1206(10)60934-9","article-title":"Safety of the intranasal toll-like receptor 4 agonist crx-675 in allergic rhinitis","volume":"97","author":"Casale","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1159\/000321826","article-title":"Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid a: a phase i\/iia study","volume":"154","author":"Pfaar","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1159\/000455047","article-title":"The impact on allergy-related cells of a birch pollen allergoid, with and without monophosphoryl lipid a, in comparison with the native equivalent","volume":"172","author":"Worm","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03783.x","article-title":"Assessment of clinical efficacy of cyt003-qbg10 in patients with allergic rhinoconjunctivitis: a phase iib study","volume":"41","author":"Klimek","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03191.x","article-title":"Use of a-type cpg oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase i\/iia clinical trial","volume":"39","author":"Senti","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/all.15788","article-title":"Short-course subcutaneous treatment with pq grass strongly improves symptom and medication scores in grass allergy","volume":"78","author":"de Kam","year":"2023","journal-title":"Allergy"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12974","article-title":"Safety and pharmacodynamics of intranasal gsk2245035, a tlr7 agonist for allergic rhinitis: a randomized trial","volume":"47","author":"Ellis","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"B113","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1465-9921-13-53","article-title":"Repeated intranasal tlr7 stimulation reduces allergen responsiveness in allergic rhinitis","volume":"13","author":"Greiff","year":"2012","journal-title":"Respir Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02012.x","article-title":"Nasal cpg oligodeoxynucleotide administration induces a local inflammatory response in nonallergic individuals","volume":"64","author":"M\u00e5nsson","year":"2009","journal-title":"Allergy"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/all.13478","article-title":"Randomized controlled trials define shape of dose response for pollinex quattro birch allergoid immunotherapy","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110316","article-title":"Nano-based vaccine delivery systems: innovative therapeutics against cancer and neurological disorders","volume":"26","author":"Ahmed","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/10611860903106034","article-title":"Stimulation of human macrophages (thp-1) using toll-like receptor-2 (tlr-2) agonist decorated nanocarriers","volume":"17","author":"Heuking","year":"2009","journal-title":"J Drug Target"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c02765","article-title":"Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines","volume":"14","author":"Shae","year":"2020","journal-title":"ACS Nano"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s558540","article-title":"Targeted-immunomodulatory nanomedicines for the treatment of autoimmune diseases via multiple administration routes","volume":"20","author":"Lee","year":"2025","journal-title":"Int J Nanomed"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121831","article-title":"Tlr3 agonist nanoscale coordination polymer synergizes with immune checkpoint blockade for immunotherapy of cancer","volume":"290","author":"Li","year":"2022","journal-title":"Biomaterials"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.6c00040","article-title":"Tlr agonist\/copper-based metformin carbon dot-loaded homologous membrane nanocarriers with enhanced immunogenic cell death for synchronous amelioration of tumor microenvironment hypoxia, immunosuppression, and metastasis inhibition","author":"Zhu","year":"2026","journal-title":"ACS Appl Mater Interfaces"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008799","article-title":"Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy","volume":"12","author":"Jeon","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113855","article-title":"Broadly active intranasal influenza vaccine with a nanocomplex particulate adjuvant targeting mast cells and toll-like receptor 9","volume":"384","author":"Ontiveros-Padilla","year":"2025","journal-title":"J Control Release"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041387","article-title":"The adjuvant effect of tlr agonists on cd4(+) effector t cells is under the indirect control of regulatory t cells","volume":"41","author":"Olivier","year":"2011","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1769878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:37:15Z","timestamp":1780634235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1769878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2026.1769878"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1769878","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"1769878"}}